Sana Biotechnology Inc

SANA

Healthcare|Biotechnology|USA

$3.85

-0.08 (-2.04%)

Upcoming Data Readouts (5)

Apr 2027

Est. completion

NARegional Anesthesia

Ultrasound-Guided Erector Spinae Plane Block Versus Thoracoscopically-Guided Intercostal Nerve Block in Video-Assisted Thoracoscopic Surgery

Jun 2027

Est. completion

Acute Ischemic Stroke

German Stroke Registry - Endovascular Treatment

Dec 2027

Est. completion

P1Lupus Erythematosus

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Dec 2030

Est. completion

Leukodystrophy

The Myelin Disorders Biorepository Project

Dec 2035

Est. completion

Lymphedema

An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025

Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)

Nov 2025

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)